T5O0 — bioXXmed AG Share News
0.000.00%
Last trade - 00:00- €1.07m
- €0.98m
- €0.02m
Brief: CytoTools: Dermapro Gets Marketing Approval In India
Brief: CytoTools's Subsidiary CytoPharma Applies For Patent In Field Of Oncology
Brief: CytoTools Successfully Placed New Tranche Of Convertible Bond For EUR 3 Mln
Brief: Cytotools Ag To Issue Further Tranche Of Convertible Bond
Brief: CytoTools Carries Out Phase II Study As Planned, Raises Stake In DermaTools
Brief: CytoTools Resolves To Issue Another Tranche Of Convertible Bond
Brief: CytoTools Increases Stake In Dermatools Biotech GmbH
Brief: CytoTools To Carry Out Capital Increase
Brief: CytoTools Acquires Majority Stake In Cytopharma GmbH
Brief: CytoTools Places Another Tranche Of Convertible Bond
Brief: CytoTools: Successful Release Of Study Drug In Europe And Start Treatment Of First Patients In Clinical Trial For Diabetic Foot Therapy
Brief: CytoTools Resolves To Issue Another Tranche Of The Convertible Bond
Brief: CytoTools Successfully Places Another Tranche Of Convertible Bond
Brief: CytoTools Resolves To Issue Convertible Bond
Brief: CytoTools: Successful With Application For Clearance At Higher Regional Court
Brief: CytoTools Starts New European Clinical Trial In Indication Of Diabetic Foot Syndrome For DermaPro
Brief: Cytotools: Dermatools And Cytopharma Receive Over EUR 1 Mln In Fresh Capital
Brief: CytoTools: Dermatools Biotech Gmbh Files Patent For Use As A Medical Device
Brief: CytoTools Submission Of European Clinical Trials For Dermapro Imminent